MetaCap

DaVita (DVA) vs Mangoceuticals (MGRX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

DaVita is the larger company by market cap ($11.28 billion vs $9.6 million), about 1178.6 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Head-to-head

DVA versus MGRX key metrics
MetricDVAMGRX
Share price$176.78$0.4437
Market cap$11.28B$9.57M
1-day change-2.01%-1.40%
YTD return+55.60%—
1-year return+34.91%—
5-year return+57.54%—
P/E ratio (TTM)14.93—
Forward P/E10.31—
EPS (TTM)$11.84$-1.02
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$13.64B—
Revenue growth (YoY)+6.46%—
Net income (latest FY)$746.80M—
Operating margin14.98%—
Net margin5.47%—
52-week high$247.49$2.75
52-week low$101.00$0.162
Distance from 52-week high-28.57%-83.87%
Analyst consensusbuy—
Avg. price target upside+24.37%—
Average volume776.03K13.02M
Shares outstanding63.80M21.57M
Employees78,000—
SectorHealth CareHealth Care
IndustryMisc Health and Biotechnology ServicesMisc Health and Biotechnology Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • DaVita is about 1178.6 times larger than Mangoceuticals by market value ($11.28B vs $9.57M).

About DaVita

DVA stock →

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States.

Health Care · Misc Health and Biotechnology Services · 78,000 employees

DVA vs MGRX FAQ

Which is bigger, DaVita or Mangoceuticals?

DaVita (DVA) is larger, with a market capitalization of $11.28B compared with $9.57M for Mangoceuticals (MGRX).

Are DaVita and Mangoceuticals in the same industry?

Yes. Both are classified in the Misc Health and Biotechnology Services industry within the Health Care sector.

More comparisons